Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Presented on .

Deaths from drug overdoses are the number one cause of injury death in the U.S. Most of these deaths are related to the misuse of prescription opioids and heroin. While men were more likely than women to die of opioid overdose, the number of overdose deaths from opioids among women has increased substantially. Since 1999, women’s deaths have quadrupled from prescription opioid overdose.

Consider the following:

  • Nearly 48,000 women died of prescription opioid overdose between 1999 and 2010.
  • For every woman who dies of a prescription opioid overdose, over 30 of them go the emergency department for opioid misuse or abuse.

Women’s biological differences may influence susceptibility to substance abuse, which could have implications for prevention and treatment. In order to identify and treat women most at risk, health care providers must be able to recognize and consider these differences.

Join us as we discuss how health care providers, researchers, and the public health community can best address the complexities of opioid use disorder among women. Speakers will give an overview of the federal response to the disorder, along with approaches to care and prevention of substance use.

Beyond the Data

Dr. John Iskander and Dr. Mishka Terplan, discuss how the opioid epidemic is impacting women differently than men. Tune in to hear how women’s gender and biological differences need to be considered when providing care and recommending policy on federal, state, and local levels.

Presented By

Karin A. Mack, PhD
Associate Director for Science,
Division of Analysis Research and Practice Integration

National Center for Injury Prevention and Control, CDC
"The Opioid Overdose Crisis and the Federal Response"
Linda Frazier, RN, MCHES, CADC
Director, Addictions Initiatives
Chair, APHA ATOD Section, Advocates for Human Potential, Inc.

"Comprehensive Approaches to Care of Women with Substance Use Disorders"
Mishka Terplan, MD, MPH, FACOG, FASAM
Professor, OBGYN and Psychiatry
Virginia Commonwealth University Medical Center
"Prevention of Substance Use Through Integration into Healthcare"

Facilitated By

John Iskander, MD, MPH
Scientific Director
Phoebe Thorpe, MD, MPH
Deputy Scientific Director
Susan Laird, MSN, RN
Communications Director

Enjoyed this Presentation?

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up

Sign Up

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Continuing Education

This session is available for Continuing Education (CE). Register here using the course information below.

CDC Course Code: PHGR10
CPE UAN: 0387-0000-17-015-H04-P

For more information, see Grand Rounds Continuing Education.

You May Also Like

Medication Adherence

February 2017, Hospital Healthcare
View of a senior woman holding medicines

Approximately half of people with a chronic condition don’t take their prescribed medications. Reasons for “medication non-adherence” are varied. Learn about the latest research, interventions, education, and emerging tools and technologies that may help overcome these barriers to medication non-adherence.

Pharmacists and Public Health

October 2014, Hospital Healthcare
Pharmacist talking to mom and baby

The expanded role of pharmacists will position them to have greater impact in health care and public health. Beyond the dispensing of medications, pharmacists also provide a spectrum of prevention and treatment services to help improve health outcomes. Learn about the importance of including pharmacists in team-based care.

  • Page last reviewed: February 28, 2018
  • Page last updated: June 25, 2018
  • Content source:
    • Office of the Associate Director for Science
    • Page maintained by: Office of the Associate Director for Communication
TOP